Clinical Trial Update: Safety and Efficacy of Acthar Gel in an Outpatient Dialysis Population [Phase 1]

View source ↗

Summary

This Phase 1 trial assessed the safety and efficacy of Acthar Gel in outpatients with end-stage renal disease on dialysis, but the study was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease

Drugs mentioned

• Acthar Gel (repository corticotropin injection)

Snippet

Sponsor: Youngstown State University | Conditions: End Stage Renal Disease | Phase 1 | Status: TERMINATED